To contentTo navigationTo search
Logotype

News & Events

Press Releases


2024

Implantica announces another major public hospital purchase agreement win in Italy, further strengthening RefluxStop™’s broader acceptance in public healthcare systems in Europe

05.03.2024
 | Other press releases
Implantica AG (publ.), a medtech company at the forefront of bringing advanced technology into the body, announces another public hospital purchase agreement for RefluxStop™ this time at the IRCCS Saverio De Bellis in Bari, Puglia, Italy.

Implantica publishes Year-end Report, January – December 2023 (Q4)

16.02.2024
 | Regulatory
RefluxStop™ – Gaining speed, breaking boundaries and going global

Implantica’s RefluxStop™ now available in Munich

15.02.2024
 | Other press releases
Implantica AG (publ.), a medtech company at the forefront of bringing advanced technology into the body, announces the first RefluxStop™ procedures completed at Artemed Klinikum München Süd in Munich, Germany.

Implantica announces first RefluxStop™ public tender win, paving the way for permanent reimbursement in Italy

13.02.2024
 | Other press releases
Implantica AG (publ.), a medtech company at the forefront of bringing advanced technology into the body, announces that Hospital Santa Croce of Moncalieri, Turin, Regione Piemonte, Italy, has won the first-ever public tender for RefluxStop™.

Implantica continues to expand in Germany with another reflux Center of Excellence in Berlin

06.02.2024
 | Other press releases
Implantica AG (publ.), a medtech company at the forefront of bringing advanced technology into the body, announces the first RefluxStop[TM] procedures completed at MIC Hospital in Berlin.

Implantica presents the fourth quarter 2023 on February 16 at 15:00 CET

05.02.2024
 | Other press releases
Implantica AG (publ) invites investors to a presentation of the fourth quarter 2023 at 15:00 CET on February 16. The interim report for the fourth quarter will be published at 8:00 a.m. CET on the same day.

Implantica's RefluxStop™ featured in seven presentations accepted at the largest US GI conference, SAGES

01.02.2024
 | Other press releases
Implantica AG (publ.), a medtech company at the forefront of bringing advanced technology into the body, reports that seven new scientific data presentations and abstracts on RefluxStop™ have been accepted at the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) Annual Scientific Meeting in Cleveland, Ohio, April 17-20, 2024.

Implantica’s RefluxStop™ procedure now available in Norway

30.01.2024
 | Other press releases
Implantica AG (publ.), a medtech company at the forefront of bringing advanced technology into the body, announces that the RefluxStop™ procedure is now available at the Akershus University Hospital in Norway.

2023

Implantica adds another RefluxStop™ center in Spain

18.12.2023
 | Other press releases
Implantica AG (publ.), a medtech company at the forefront of bringing advanced technology into the body, announces another key public hospital in Spain successfully completed its first RefluxStop™ procedures.

Implantica announces live surgery with RefluxStop™ attended by nearly 2’000 surgeons and streamed by up to 100’000 online

05.12.2023
 | Other press releases
Implantica AG (publ), a medtech company at the forefront of bringing advanced technology into the body, announces that the RefluxStop™ procedure was included in a live surgical demonstration at the 34[th] Congress of Digestive System Surgery in Rome, Italy, where nearly 90’000 were international viewers.
Load more